IP Library › Assignment 023708/0389
Patent Assignment
Reel/Frame 023708/0389

Security Agreement

Recorded: 2009-12-29 Received: 2009-12-29 Pages: 71
Assignors
MDRNA RESEARCH, INC.
Executed: 2009-12-22
MDRNA, INC.
Executed: 2009-12-22
Assignee
EOS HOLDINGS LLC, AS AGENT
1068 EAST MAIN STREET, SUITE 140E, VENTURA, CA, 93001, UNITED STATES
Covered Properties (97)
Usirna Complexes
Compositions and Methods for Triggered Release Rna Therapeutics
Amino Acid-Based Nanoparticle Formulations
Application: 61/258,115 →
Processes and Compositions for Liposomal and Efficient Delivery of Gene Silencing Therapeutics
Rna Complexes Comprising Acyclic Nucleomonomers
Application: 61/252,085 →
Nucleic Acid Compounds for Inhibiting Gene Expression and Uses Thereof
Application: 12/552,082 →
Nucleic Acid Compounds for Inhibiting Wnt Gene Expression and Uses Thereof
Application: 12/529,532 →
Nucleic Acid Compounds for Inhibiting Ras Gene Expression and Uses Thereof
Application: 12/529,302 →
Nucleic Acid Compounds for Inhibiting Myc Gene Expression and Uses Thereof
Application: 12/529,138 →
Nucleic Acid Compounds for Inhibiting BCL2 Gene Expression and Uses Thereof
Application: 12/529,011 →
Nucleic Acid Compounds for Inhibiting HIF1A Gene Expression and Uses Thereof
Application: 12/528,786 →
Nucleic Acid Compounds for Inhibiting Erbb Family Gene Expression and Uses Thereof
Application: 12/528,619 →
Nucleic Acid Compounds for Inhibiting Vegf Family Gene Expression and Uses Thereof
Application: 12/528,508 →
Nucleic Acid Compounds for Inhibiting BIRC5 Gene Expression and Uses Thereof
Nucleic Acid Compounds for Inhibiting PLK1 Gene Expression and Uses Thereof
Ribonucleic Acids with Non-Standard Bases and Uses Thereof
Application: 12/486,889 →
Multi-Arm Amines and Uses Thereof
Hydroxymethyl Substituted Rna Oligonucleotides and Rna Complexes
Application: 12/515,403 →
Compositions and Methods for Efficient Delivery of Gene Silencing Therapeutics
Application: 61/167,379 →
Rna Oligonucleotides and Rna Complexes Comprising Acyclic Nucleomonomers
Application: 61/119,624 →
Compositions and Methods for Triggered Release Therapeutics
Application: 61/116,258 →
Compositions and Methods for Liposomal Rna Therapeutics
Application: 61/106,062 →
Lipopeptides for Delivery of Nucleic Acids
Compositions and Methods for Enhancing Delivery of Nucleic Acids into Cells and for Modifying Expression of Target Genes in Cells
Application: 12/206,165 →
Modification of Double-Stranded Ribonucleic Acid Molecules
Application: 12/065,604 →
Uses of Broad Spectrum Rnai Therapeutics Against Influenza
Application: 12/189,563 →
Nucleic Acid Compounds for Inhibiting PLK1 Gene Expression and Uses Thereo
Application: 61/086,445 →
Nucleic Acid Compounds for Inhibiting BIRC5 Gene Expression and Uses Thereof
Application: 61/086,435 →
Ribonucleic Acids with Non-Standard Bases and Uses Thereof
Application: 61/073,633 →
Lipophilic Amines and Uses Thereof
Application: 61/057,153 →
Hydroxymethyl Substituted Rna Oligonucleotides and Rna Complexes
Amino Acid Lipids and Uses Thereof
Nucleic Acid Compounds for Inhibiting Myc Gene Expression and Uses Thereof
Nucleic Acid Compounds for Inhibiting Wnt Gene Expression and Uses Thereof
Nucleic Acid Compounds for Inhibiting Ras Gene Expression and Uses Thereof
Nucleic Acid Compounds for Inhibiting BCL2 Gene Expression and Uses Thereof
Nucleic Acid Compounds for Inhibiting Akt Gene Expression and Uses Thereof
Nucleic Acid Compounds for Inhibiting Erbb Family Gene Expression and Uses Thereof
Nucleic Acid Compounds for Inhibiting Vegf Gene Expression and Uses Thereof
Application: 12/039,650 →
Nucleic Acid Compounds for Inhibiting Apob Gene Expression and Uses Thereof
Application: 12/039,668 →
Nucleic Acid Compounds for Inhibiting Vegf Family Gene Expression and Uses Thereof
Nucleic Acid Compounds for Inhibiting Akt Gene Expression and Uses Thereof
Application: 12/039,662 →
Nucleic Acid Compounds for Inhibiting Erbb Gene Expression and Uses Thereof
Application: 12/039,658 →
Nucleic Acid Compounds for Inhibiting HIF1A Gene Expression and Uses Thereof
Dispersion Compositions for Interfering Rna and Uses Thereof
Application: 61/022,571 →
Methods and Compositions for Enhancing Delivery of Double-Stranded Rna or a Double-Stranded Hybrid Nucleic Acid to Regulate Gene Expression in Mammalian Cells
Application: 12/013,274 →
Nucleic Acid Compounds for Inhibiting WNT3A Gene Expression and Uses Thereof
Application: 61/015,611 →
Nucleic Acid Compounds for Inhibiting AKT3 Gene Expression and Uses Thereof
Application: 61/013,239 →
Nucleic Acid Compounds for Inhibiting AKT2 Gene Expression and Uses Thereof
Application: 61/013,212 →
Phage Displayed Trp Cage Ligands
Application: 11/955,207 →
Nucleic Acid Compounds for Inhibiting BCL2 Gene Expression and Uses Thereof
Application: 60/989,419 →
Nucleic Acid Compounds for Inhibiting Nras Gene Expression and Uses Thereof
Application: 60/988,400 →
Nucleic Acid Compounds for Inhibiting Kras Gene Expression and Uses Thereof
Application: 60/988,402 →
Nucleic Acid Compounds for Inhibiting Myc Gene Expression and Uses Thereof
Application: 60/988,395 →
Nucleic Acid Compounds for Inhibiting Hras Gene Expression and Uses Thereof
Application: 60/988,401 →
Nicked or Gapped Nucleic Acid Molecules and Uses Thereof
Uses of Broad Spectrum Rnai Therapeutics Against Influenza
Application: 60/979,772 →
Rnai Therapeutic for Respiratory Virus Infection
Application: 11/910,971 →
Lipopeptides for Delivery of Interfering Rna Agents
Application: 60/976,894 →
Nucleic Acid Compounds for Inhibiting RAF1 Gene Expression and Uses Thereof
Application: 60/973,397 →
Nucleic Acid Compounds for Inhibiting AKT1 Gene Expression and Uses Thereof
Application: 60/973,398 →
Emulsion Compositions for Interfering Rna and Uses Thereof
Application: 60/972,590 →
Amino Acid Lipids and Uses for Rna Therapeutics
Application: 60/972,653 →
Nucleic Acid Compounds for Inhibiting HIF1A Gene Expression and Uses Thereof
Application: 60/956,093 →
Dicer Substrate Rna Peptide Conjugates and Methods for Rna Therapeutics
Compositions and Methods of Using Double-Stranded Nucleic Acid Molecules Containing One or More Gap or Nick
Application: 60/955,317 →
Rna Therapeutics for Drug Resistant Influenza
Application: 60/955,314 →
Amino Acid Lipid Compositions and Methods for Delivering Rna Therapeutics
Application: 60/953,667 →
Device for Improved Peptide Delivery
Application: 11/774,492 →
Hockey Stick
Application: 11/772,662 →
Amino Acid Lipid Compositions and Methods for Delivering Rna Therapeutics
Application: 60/947,282 →
Nucleic Acid Compounds for Inhibiting Erbb Family Gene Expression and Uses Thereof
Application: 60/932,970 →
FORMULATIONS FOR INTRACELLULAR DELIVERY dsRNA
Application: 11/750,979 →
Nucleic Acid Compounds for Inhibiting ERBB4 Gene Expression and Uses Thereof
Application: 60/934,922 →
Nucleic Acid Compounds for Inhibiting ERBB3 Gene Expression and Uses Thereof
Application: 60/934,935 →
Nucleic Acid Compounds for Inhibiting Egfr Gene Expression and Uses Thereof
Application: 60/934,945 →
Amino Acid Lipid Compositions and Methods for Delivering Rna Therapeutics
Application: 60/916,131 →
Nucleic Acid Compounds for Inhibiting ERBB2 Gene Expression and Uses Thereof
Application: 60/934,946 →
Nucleic Acid Compounds for Inhibiting Vegf Family Gene Expression and Uses Thereof
Application: 60/932,949 →
COMPOSITIONS AND METHODS FOR LIPID AND POLYPEPTIDE BASED siRNA INTRACELLULAR DELIVERY
Application: 11/743,480 →
Nucleic Acid Compounds for Inhibiting Figf Gene Expression and Uses Thereof
Application: 60/934,943 →
Nucleic Acid Compounds for Inhibiting Pgf Gene Expression and Uses Thereof
Application: 60/934,934 →
Nucleic Acid Compounds for Inhibiting Vegfb Gene Expression and Uses Thereof
Application: 60/934,928 →
Nucleic Acid Compounds for Inhibiting Vegf Gene Expression and Uses Thereof
Application: 60/934,931 →
Compositions and Methods of Using Gapped or Nicked Double Stranded Nucleic Acid Molecules
Application: 60/910,393 →
Method of Treating an Inflammatory Disease by Double Stranded Ribonucleic Acid
Application: 11/576,139 →
Rnai Therapeutic for Respiratory Virus Infection
Application: 11/687,564 →
Compounds for Inhibiting Gene Expression by Ribonucleic Acid Interference and Uses Thereof
Application: 60/934,930 →
Compounds for Inhibiting Tnf Gene Expression by Ribonucleic Acid Interference and Uses Thereof
Application: 60/934,940 →
CATIONIC PEPTIDES FOR siRNA INTRACELLULAR DELIVERY
Application: 11/676,221 →
Compositions and Methods for Complexes of Nucleic Acids and Organic Cations
Application: 11/676,226 →
Phage Displayed Cell Binding Peptides
Application: 11/627,863 →
Dry Powder Compositions for Rna Influenza Therapeutics
Application: 11/623,306 →
COMPOSITIONS AND METHODS EMPLOYING UNIVERSAL-BINDING NUCLEOTIDES FOR TARGETING MULTIPLE GENE VARIANTS WITH A SINGLE siRNA DUPLEX
Application: 11/610,403 →
Peptide-Dicer Substrate Rna Conjugates as Delivery Vehicles for Sirna
COMPOSITIONS AND METHODS EMPLOYING GAPPED OR NICKED siRNA MOLECULES
Application: 60/862,027 →
Compounds and Methods for Peptide Ribonucleic Acid Condensate Particles for Rna Therapeutics